Detalhe da pesquisa
1.
Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing.
Cancer Immunol Immunother
; 67(9): 1437-1447, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030557
2.
CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time.
Int J Mol Sci
; 18(5)2017 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28498319
3.
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
J Ovarian Res
; 17(1): 71, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38566237
4.
Crystallization and preliminary X-ray analysis of the complexes between a Fab and two forms of human insulin-like growth factor II.
Acta Crystallogr Sect F Struct Biol Cryst Commun
; 65(Pt 9): 945-8, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19724140
5.
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival.
Oncotarget
; 9(38): 24992-25007, 2018 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29861848
6.
Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma.
PLoS One
; 13(7): e0201314, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30052649
7.
Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau.
Oncotarget
; 9(33): 23289-23305, 2018 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29796189
8.
Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1.
J Leukoc Biol
; 80(4): 905-14, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16888085
9.
Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade.
Arthritis Rheumatol
; 68(2): 521-31, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26315469
10.
Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
J Natl Cancer Inst
; 107(4)2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25710962
11.
New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.
Biochem Res Int
; 2011: 191670, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21152183
12.
A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo.
Mol Cancer Ther
; 9(6): 1809-19, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20515953
13.
Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.
Cancer Res
; 69(4): 1517-26, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19208838
14.
PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor.
Neoplasia
; 9(11): 927-37, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18030361
15.
Discovery of human antibodies against the C5aR target using phage display technology.
J Mol Recognit
; 18(4): 327-33, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15706605